Next generation platinum salt in nasopharygeal carcinoma

In The Lancet Oncology, Xing Lv and colleagues present their study showing that 5-year progression-free survival with lobaplatin-based induction chemotherapy and concomitant chemoradiotherapy was not inferior to a cisplatin-based strategy in patients with curable advanced nasopharyngeal cancer. 1 Lv X Cao X Xia W-X et al. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in...